Breaking News

Over a quarter ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Get Free Trial
Send Info
Hot Stocks
Pulmatrix to stop patient enrollment of the Ph2b study of PUR1900 » 09:07
01/08/24
01/08
09:07
01/08/24
09:07
PULM

Pulmatrix

$2.07 /

-0.04 (-1.90%)

Pulmatrix announced that…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Pulmatrix's IND application for PUR3100 to treat acute migraine accepted by FDA » 09:07
09/19/23
09/19
09:07
09/19/23
09:07
PULM

Pulmatrix

$2.22 /

-0.11 (-4.72%)

Pulmatrix announced the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Pulmatrix submits NDA to FDA to initiate Phase 2 trial of PUR3100 » 09:07
07/11/23
07/11
09:07
07/11/23
09:07
PULM

Pulmatrix

$2.72 /

+ (+0.00%)

Pulmatrix announced the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Pulmatrix to present Phase 1 data of PUR3100 in acute migraine » 09:26
06/15/23
06/15
09:26
06/15/23
09:26
PULM

Pulmatrix

$2.66 /

-0.04 (-1.48%)

Pulmatrix will present…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.